Media Summary: CNBC's Meg Tirrell dissects the latest biotech news making headlines today, including raising the price for Daraprim from $13.50 ... Fortune's Alan Murray and Aaron Task explain.

Turing Ceo Martin Shkreli Talks - Detailed Analysis & Overview

CNBC's Meg Tirrell dissects the latest biotech news making headlines today, including raising the price for Daraprim from $13.50 ... Fortune's Alan Murray and Aaron Task explain.

Photo Gallery

Turing CEO Martin Shkreli Talks 5,000% Drug Price Hike (Full Interview) | CNBC
Turing Pharmaceuticals CEO Martin Shkreli speaks to CNBC
Forbes Martin Shkreli FULL Interview
Turing Pharmaceuticals CEO defends Daraprim price hike
Turing Pharmaceuticals CEO Martin Shkreli speaks
Exclusive: Martin Shkreli Interview
Martin Shkreli's Attorney: Former Turing Pharma CEO Is A 'Genius' | CNBC
Turing CEO defends 5,000% price increase on AIDS drug
Shkreli: Price Increase Has Stuck, Happy With That
Martin Shkreli Testifies Before Congress: Full Testimony | CNBC
Former Turing Pharma CEO Martin Shkreli Excused From Hearing | CNBC
How Martin Shkreli Ruined the Pharmaceutical Industry | Fortune
Sponsored
Sponsored
View Detailed Profile
Turing CEO Martin Shkreli Talks 5,000% Drug Price Hike (Full Interview) | CNBC

Turing CEO Martin Shkreli Talks 5,000% Drug Price Hike (Full Interview) | CNBC

CNBC's Meg Tirrell dissects the latest biotech news making headlines today, including raising the price for Daraprim from $13.50 ...

Turing Pharmaceuticals CEO Martin Shkreli speaks to CNBC

Turing Pharmaceuticals CEO Martin Shkreli speaks to CNBC

Turing

Sponsored
Forbes Martin Shkreli FULL Interview

Forbes Martin Shkreli FULL Interview

"

Turing Pharmaceuticals CEO defends Daraprim price hike

Turing Pharmaceuticals CEO defends Daraprim price hike

Don Dahler spoke to

Turing Pharmaceuticals CEO Martin Shkreli speaks

Turing Pharmaceuticals CEO Martin Shkreli speaks

Turing

Sponsored
Exclusive: Martin Shkreli Interview

Exclusive: Martin Shkreli Interview

Fox 5 Anchor Steve Lacy interviewed

Martin Shkreli's Attorney: Former Turing Pharma CEO Is A 'Genius' | CNBC

Martin Shkreli's Attorney: Former Turing Pharma CEO Is A 'Genius' | CNBC

Martin Shkreli's

Turing CEO defends 5,000% price increase on AIDS drug

Turing CEO defends 5,000% price increase on AIDS drug

Turing Founder Martin Shkreli

Shkreli: Price Increase Has Stuck, Happy With That

Shkreli: Price Increase Has Stuck, Happy With That

Dec.23 -- Former

Martin Shkreli Testifies Before Congress: Full Testimony | CNBC

Martin Shkreli Testifies Before Congress: Full Testimony | CNBC

Former

Former Turing Pharma CEO Martin Shkreli Excused From Hearing | CNBC

Former Turing Pharma CEO Martin Shkreli Excused From Hearing | CNBC

Former

How Martin Shkreli Ruined the Pharmaceutical Industry | Fortune

How Martin Shkreli Ruined the Pharmaceutical Industry | Fortune

Fortune's Alan Murray and Aaron Task explain.

Who is Turing Pharmaceuticals' Martin Shkreli?

Who is Turing Pharmaceuticals' Martin Shkreli?

Turing